T. Tanaka et al., Identification of leukemia inhibitory factor as a potent mast cell growth-enhancing factor produced by mouse keratinocyte cell line, KCMH-1, ARCH DERM R, 293(1-2), 2001, pp. 18-25
Inoculation of KCMH-1 cells, a keratinocyte-derived cell line established f
rom a chemically induced skin tumor, into the skin of mice results in accum
ulation of mast cells around the resulting tumors, The conditioned medium o
f KCMH-1 cells enhances the growth of mast cells in vitro when they are cul
tured in the presence of NIH/3T3 fibroblasts, suggesting an important role
for keratinocytes in mast cell hyperplasia in the skin, The aim of this stu
dy was to identify this mast cell growth-enhancing factor (MCGEF) by screen
ing a KCMH-1 cDNA library. We first established a polyclonal antibody raise
d against the partially purified factor obtained from KCMH-1-conditioned me
dium which neutralized the MCGEF activity in KCMH-1-conditioned medium. Exp
ression cloning of 1 X 10(6) cDNAs from the KCMH-1 cDNA library led to 16 c
DNAs, One of these cloned cDNAs was found to be leukemia inhibitory factor
(LIF). Both LIF produced by COS cells and the recombinant protein obtained
commercially showed MCGEF activity when added to mast cell/fibroblast cocul
tures, MCGEF activity in KCMH-1-conditioned medium was completely neutraliz
ed by an anti-LIE monoclonal antibody, These results suggest that MCGEF pro
duced by KCMH-1 cells is identical to LIF.